Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026)
Aquestive Therapeutics' (AQST) quarterly Times Interest Earned came in at -$0.57 in Q1 2026, up 74.51% year-on-year from -$0.32 in Q1 2025, and down 104.4% quarter-over-quarter from $12.85 in Q4 2025.
Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$0.57 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 74.51% year-over-year to -$0.57 in Q1 2026; TTM through Mar 2026 was -$7.52, a 59.34% decrease from a year earlier, with the FY2025 full-year figure at -$0.63, down 92.91% from the prior year.
- Times Interest Earned declined to -$0.57 in Q1 2026 per AQST's latest filing, from $12.85 in the prior quarter.
- Across five years, Times Interest Earned topped out at $12.85 in Q4 2025 and bottomed at -$6.49 in Q4 2022.
- The 5-year median for Times Interest Earned is -$0.91 (2024), against an average of -$0.89.
- Biggest YoY gain for Times Interest Earned was 609.26% in 2025; the steepest drop was 23879.54% in 2025.
- Year by year, Times Interest Earned stood at -$6.49 in 2022, then soared by 66.06% to -$2.2 in 2023, then surged by 182.24% to $1.81 in 2024, then jumped by 609.26% to $12.85 in 2025, then sank by 104.4% to -$0.57 in 2026.
- Per Business Quant, the three latest AQST Times Interest Earned figures stand at -$0.57 (Q1 2026), $12.85 (Q4 2025), and -$3.86 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | 12.85 |
| Sep 30, 2025 | -3.86 |
| Jun 30, 2025 | -1.35 |
| Mar 31, 2025 | -2.22 |
| Dec 31, 2024 | 1.81 |
| Sep 30, 2024 | -0.89 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | -2.20 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -6.49 |
| Sep 30, 2022 | -3.14 |
| Jun 30, 2022 | -4.05 |
| Mar 31, 2022 | -2.81 |
| Dec 31, 2021 | -6.69 |
| Sep 30, 2021 | -1.94 |
| Jun 30, 2021 | -1.47 |